跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,163 条关于
“ALPHA2”
全部
2,163
临床试验
1,438
药物
585
机构
16
资讯
124
去年
Allogene Pauses Cema-Cel Trial Enrollment, Prioritizes Other Programs
去年
FDA Lifts Clinical Hold on Allogene's AlloCAR T Studies After Safety Investigation Clears Manufacturing Process
2年前
Allogene Therapeutics Pivots Strategy with Pipeline Restructuring and 22% Workforce Reduction
去年
Allogene's CAR T-Cell Therapy Shows Promising Results in Large B-Cell Lymphoma Trials
去年
Galimedix Therapeutics Initiates Phase 1 Trial of Oral GAL-101 for Amyloid Beta Modulation
去年
Cema-cel Shows Promising 2-Year Durability Data in Large B-Cell Lymphoma Treatment
去年
Genenta Reports 3-Year Survival in Glioblastoma Patients with Temferon Cell Therapy
去年
Bayer Advances Pharma Pipeline with Regulatory Filings and Clinical Milestones
2年前
Off-The-Shelf Allogeneic CAR-T Therapies Show Promise for B-Cell Malignancies
2个月前
Bausch + Lomb Halts Glaucoma Program for BL1107 Eye Drops After Phase 2 Miss, Shifts Focus to Geographic Atrophy Implant
第 1 页,共 13 页
上一页
下一页